Relations of serum phosphorus levels to echocardiographic left ventricular mass and incidence of heart failure in the community
about
Hyperphosphatemia Management in Patients with Chronic Kidney DiseaseEffect of niacin on FGF23 concentration in chronic kidney disease.Serum magnesium, phosphorus, and calcium are associated with risk of incident heart failure: the Atherosclerosis Risk in Communities (ARIC) StudyThe relation between serum phosphorus levels and clinical outcomes after acute myocardial infarctionLeft ventricular hypertrophy and chronic renal insufficiency in the elderly.Fibroblast growth factor-23 and incident coronary heart disease, heart failure, and cardiovascular mortality: the Atherosclerosis Risk in Communities study.Phosphate, fibroblast growth factor 23 and retinopathy in chronic kidney disease: the Chronic Renal Insufficiency Cohort Study.Effects of a high-protein diet on regulation of phosphorus homeostasis.Serum phosphorus and association with anemia among a large diverse population with and without chronic kidney disease.Dietary phosphorus is associated with greater left ventricular massRelation of serum phosphorus levels to the incidence of atrial fibrillation (from the Atherosclerosis Risk In Communities [ARIC] study).Cardiovascular effects of sevelamer in stage 3 CKD.Fibroblast Growth Factor-23 (FGF-23) Levels Differ Across Populations by Degree of IndustrializationApoptosis-mediated endothelial toxicity but not direct calcification or functional changes in anti-calcification proteins defines pathogenic effects of calcium phosphate bions.Mineral and Bone Disorder and Its Association with Cardiovascular Parameters in Chinese Patients with Chronic Kidney DiseaseAssociation of serum calcium and heart failure with preserved ejection fraction in patients with type 2 diabetes.Heart Failure in Women--Insights from the Framingham Heart Study.Coronary artery calcification in chronic kidney disease: An update.Phosphate additives in food--a health risk.Phosphate in early chronic kidney disease: associations with clinical outcomes and a target to reduce cardiovascular risk.Chronic kidney disease and vascular remodelling: molecular mechanisms and clinical implications.Phosphate is a vascular toxin.Roles of phosphate and fibroblast growth factor 23 in cardiovascular disease.Left Ventricular Diastolic Dysfunction in End-Stage Kidney Disease: Pathogenesis, Diagnosis, and Treatment.Serum Phosphate and Retinal Microvascular Changes: The Multi-Ethnic Study of Atherosclerosis and the Beaver Dam Eye Study.The New Nordic Diet: phosphorus content and absorption.Nocturnal hemodialysis: analysis following the Frequent Hemodialysis Network trial.Vitamin D status: to be considered in heart failure patients!Low Serum Phosphorus Correlates with Cerebral Aβ Deposition in Cognitively Impaired Subjects: Results from the KBASE Study.Calcium, phosphate and calcium phosphate product are markers of outcome in patients with chronic heart failure.Inorganic phosphate and FGF-23 predict outcome in stable systolic heart failure
P2860
Q26743842-68733DCA-DC9C-4207-9361-CAFFC31A10ABQ33914268-CF189173-16E6-4939-A88B-7451DC268052Q34056118-9347D6E0-65BB-410B-B2F0-EDF0F6551C01Q34625745-CC61B6DD-D75D-42A7-9F69-ECC4F33BD71EQ34985754-EDF23D3F-224A-4AE6-8B7D-939734FA4919Q35021985-64024EC0-1D94-4E72-A884-71507BAF4394Q35998095-79CFA92A-27EB-4FE0-8709-5ED9FCE25BAEQ36663079-588CBCEF-20FE-4FC9-9D66-9D057B6FF011Q36722347-046BC3BC-3ADC-49A7-976E-D6EC032DEF7CQ36728820-E9256CCB-90AB-44FE-9215-FD5B3E50265CQ36784276-FF86BD17-7722-44D2-A8A0-BA37B238649DQ36796599-B11E9D1B-7020-41C3-A7EA-C5CC27F050ADQ36911491-7F49094B-5819-4066-92A8-0FB8072CD4B9Q36959690-C453C843-A85A-4BC9-9DE2-2D7C270CD812Q37291977-66E14181-0BB2-42F4-802D-CC2CC3F59016Q37307783-E679BB15-3FDE-4AB7-A0DB-571355E38B12Q37637447-B3D3ECA5-9AD8-4F43-931A-97DCC72A8AA2Q37722763-BD227078-6015-4A79-9AA9-459A3396EEC5Q37984042-A6D24FED-E0A7-4E66-A12B-AAC7C58035AFQ38009044-6A1D87DE-1E1F-4E09-B00D-B6BF92CD0936Q38016491-B744C4E1-9E3E-4C09-B06E-BC9829A19285Q38060627-C99234F6-4B10-45A2-8DCE-A29A2D320C16Q38200883-63A36AC6-4347-400C-8D33-4C85916809ABQ38444264-1713C5AD-610F-4532-85DF-CBEDACEDBBB3Q38840495-6275314B-BD13-465A-B553-0F5C1DC395B8Q40962744-32B385D1-E3A1-4FE8-8AB3-646FF25B51C1Q43508756-47FBF4BE-704E-48B0-AFEA-E18048C27B24Q43706682-54C5F8E1-DBBF-4941-92DB-354FE77BC6ECQ47096316-27E07C59-370E-411E-B9A0-476916166666Q52840100-41B73ACE-BE74-4E83-88B2-2F81EC76D94FQ57909796-BA54621B-99D7-4185-A231-523F5E41E72E
P2860
Relations of serum phosphorus levels to echocardiographic left ventricular mass and incidence of heart failure in the community
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Relations of serum phosphorus ...... heart failure in the community
@ast
Relations of serum phosphorus ...... heart failure in the community
@en
Relations of serum phosphorus ...... heart failure in the community
@nl
type
label
Relations of serum phosphorus ...... heart failure in the community
@ast
Relations of serum phosphorus ...... heart failure in the community
@en
Relations of serum phosphorus ...... heart failure in the community
@nl
prefLabel
Relations of serum phosphorus ...... heart failure in the community
@ast
Relations of serum phosphorus ...... heart failure in the community
@en
Relations of serum phosphorus ...... heart failure in the community
@nl
P2093
P2860
P50
P356
P1476
Relations of serum phosphorus ...... heart failure in the community
@en
P2093
Jayashri Aragam
Ralph B D'Agostino
Ravi Dhingra
Thomas J Wang
William B Kannel
P2860
P304
P356
10.1093/EURJHF/HFQ106
P577
2010-08-01T00:00:00Z